Epitomee Medical Ltd
EPTMF
$0.9892
-$0.0327-3.20%
OTC PK
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.89% | 45.58% | 45.58% | 45.58% | -11.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -99.19% | -- | -- | -- | -- |
| Total Operating Expenses | -77.13% | -6.17% | -6.17% | -6.17% | 236.87% |
| Operating Income | -548.66% | 6.17% | 6.17% | 6.17% | 117.17% |
| Income Before Tax | -225.20% | -7.04% | -7.04% | -7.04% | 174.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -225.20% | -7.04% | -7.04% | -7.04% | 174.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -225.20% | -7.04% | -7.04% | -7.04% | 174.21% |
| EBIT | -548.66% | 6.17% | 6.17% | 6.17% | 117.17% |
| EBITDA | -481.80% | 3.78% | 3.78% | 3.78% | 119.17% |
| EPS Basic | -225.00% | -6.49% | -6.49% | -6.49% | 173.51% |
| Normalized Basic EPS | -224.94% | 3.40% | 3.40% | 3.40% | 173.47% |
| EPS Diluted | -225.00% | -6.49% | -6.49% | -6.49% | 173.51% |
| Normalized Diluted EPS | -224.94% | 3.40% | 3.40% | 3.40% | 173.47% |
| Average Basic Shares Outstanding | 0.09% | 0.54% | 0.54% | 0.54% | 1.08% |
| Average Diluted Shares Outstanding | 0.09% | 0.54% | 0.54% | 0.54% | 1.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |